BRAF-Mutated mCRC: The First-Line Breakthrough Patients Have Been Waiting For
New evidence from the BREAKWATER trial signals a major shift in treating BRAF-mutated metastatic colorectal cancer, moving targeted therapy into th...
A Turning Point Before Surgery: CASSANDRA Redefines Neoadjuvant Therapy in Pancreatic Cancer
The CASSANDRA phase III trial shows that the PAXG regimen significantly improves outcomes over mFOLFIRINOX in resectable pancreatic cancer. This pa...
BATTMAN Trial Targets Breakthrough in Hard-to-Treat Colorectal Cancer
A new Phase III trial, BATTMAN, explores combination immunotherapy for MSS metastatic colorectal cancer, a group with limited options. By targeting...
ASCO 2025: New Insights and Hope for Colorectal Cancer Patients
Exercise, targeted therapy, immunotherapy, and aspirin: ASCO 2025 showcased breakthroughs in colorectal cancer care that support longer survival an...
New Study Highlights How Patient and Tumour Characteristics Change Across Treatment Lines in mCRC
A new study using the ARCAD database reveals how patient and tumour traits shift across treatment lines in metastatic colorectal cancer. Findings s...
Global Collaboration for Early-Onset Colorectal Cancer: Join the Conversation
We’re proud to join the Global Early Onset Colorectal Cancer Think Tank this June in Barcelona. Alongside Fight CRC, we’re gathering patient an...
Listening to Patients: DiCE Study on Early-Onset Colorectal Cancer Published in BMC Gastroenterology
DiCE’s latest study, now published in BMC Gastroenterology, captures the experiences of 47 people under 50 diagnosed with colorectal cancer. Fin...
Ponsegromab: A New Hope for Cancer Cachexia Treatment
Cancer cachexia, a severe wasting syndrome often experienced by patients with advanced cancer, leads to substantial weight loss, muscle wasting, an...
WECAN Evidence-Based Advocacy Workshop
From 17-19 January, Lāsma Nikolaisone, a patient advocate from “Onkoalianse”, a member organisation of Digestive Cancers Europe in Lat...
Educational Booklets For Togas Pilot Studies Participants Are Now Available
Crafted with input from both patients and field experts, these booklets will undergo translation into national languages before distribution among ...